(VIANEWS) - Origin Bancorp (OBNK), FormFactor (FORM), Prospect Capital Corporation (PSEC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Origin Bancorp (OBNK)
11.5% sales growth and 15.56% return on equity
Origin Bancorp, Inc. is a bank holding firm for Origin Bank. It provides financial and banking services to low- and middle-income individuals, small businesses, cities, wealthy people, as well as retail customers in Louisiana, Texas, Mississippi, and Texas.
Origin Bancorp's sales growth this year is expected to be 9.4% and 27.8% for next year.
Year-on-year quarterly revenue growth declined by 3.1%, now sitting on 286.99M for the twelve trailing months.
Volume
Today's last reported volume for Origin Bancorp is 31723 which is 44.92% below its average volume of 57598.
Origin Bancorp's sales growth for the next quarter is 11.5%. The company's growth estimates for the ongoing quarter and the next is a negative 24.8% and negative -50.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.56%.
Volatility
Origin Bancorp's last day, last week, and last month's current intraday variation average was 0.72%, 0.48%, and 1.18%, respectively.
Origin Bancorp's highest amplitude of average volatility was 1.98% (day), 3.10% (last week), and 3.20% (last month), respectively.
Origin Bancorp's Stock Yearly Top and Bottom Value
Origin Bancorp's stock is valued at $37.41 at 06:22 EST, way below its 52-week high of $47.58 and higher than its 52-week low of $37.04.
Origin Bancorp's Moving Average
Origin Bancorp's worth is under its 50-day moving average of $41.30 and way under its 200-day moving average of $42.58.2. FormFactor (FORM)
11.2% sales growth and 11.68% return on equity
FormFactor, Inc. manufactures, sells, and designs probe cards, analytic probes, probe stations, probe stations, metrology system, thermal systems, cryogenic systems, and probe cards for semiconductor companies and scientific research institutions.
FormFactor's sales growth this year is anticipated to be 7.6% and 7% for next year.
Year-on-year quarterly revenue growth grew by 5.6%, now sitting on 780.21M for the twelve trailing months.
Volume
Today's last reported volume for FormFactor is 291450 which is 11.48% below its average volume of 329259.
FormFactor's sales growth for the next quarter is 11.2%. The company's growth estimates for the current quarter and the next is 19.4% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.68%.
Volatility
FormFactor's last day, last week, and last month's current intraday variation average was 0.33%, 2.25%, and 3.06%, respectively.
FormFactor's highest amplitude of average volatility was 6.18% (day), 4.30% (last week), and 4.75% (last month), respectively.
FormFactor's Stock Yearly Top and Bottom Value
FormFactor's stock is valued at $39.30 at 06:22 EST, way under its 52-week high of $47.48 and way above its 52-week low of $32.71.
FormFactor's Moving Average
FormFactor's worth is below its 50-day moving average of $39.33 and below its 200-day moving average of $40.14.3. Prospect Capital Corporation (PSEC)
10.7% sales growth and 23.78% return on equity
Prospect Capital Corporation (or simply Prospect Capital Corporation) is a company that specializes in business development.
Prospect Capital Corporation's sales growth this year is expected to be 12.4% and 1% for next year.
Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 661.64M for the twelve trailing months.
Volume
Today's last reported volume for Prospect Capital Corporation is 2430420 which is 43.02% above its average volume of 1699240.
Prospect Capital Corporation's sales growth is a negative 0% for the present quarter and 10.7% for the next. The company's growth estimates for the present quarter and the next is a negative 5.3% and negative -5.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.78%.
Volatility
Prospect Capital Corporation's last day, last week, and last month's current intraday variation average was 1.36%, 1.74%, and 2.39%, respectively.
Prospect Capital Corporation's highest amplitude of average volatility was 3.87% (day), 3.27% (last week), and 3.36% (last month), respectively.
Prospect Capital Corporation's Stock Yearly Top and Bottom Value
Prospect Capital Corporation's stock is valued at $7.39 at 06:22 EST, way below its 52-week high of $9.25 and above its 52-week low of $7.23.
Prospect Capital Corporation's Moving Average
Prospect Capital Corporation's value is under its 50-day moving average of $8.00 and below its 200-day moving average of $8.21.4. Zoetis (ZTS)
8% sales growth and 47.76% return on equity
Zoetis Inc. develops, produces, markets, and sells diagnostic and animal medicine products, vaccines and other health products within the United States as well as internationally.
Zoetis's sales growth this year is anticipated to be 15.1% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 7.62B for the twelve trailing months.
Volume
Today's last reported volume for Zoetis is 1367860 which is 39.48% below its average volume of 2260190.
Zoetis's sales growth is a negative 0% for the present quarter and 8% for the next. The company's growth estimates for the present quarter and the next is 0.9% and 11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.76%.
Volatility
Zoetis's last day, last week, and last month's current intraday variation average was 3.74%, 2.95%, and 0.98%, respectively.
Zoetis's highest amplitude of average volatility was 3.04% (day), 2.71% (last week), and 2.02% (last month), respectively.
Zoetis's Stock Yearly Top and Bottom Value
Zoetis's stock is valued at $171.37 at 06:22 EST, way under its 52-week high of $231.91 and way above its 52-week low of $141.41.